SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MDCO: Medicines Company -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (11)9/4/2001 3:36:24 PM
From: Biomaven  Respond to of 125
 
tuck,

FWIW, here is a different PR of the HERO-2 study:

escardio.org

I don't follow this class of drugs, so I don't know how it compares with, e.g., the Aventis low molecular weight heparin that is also available. In general I'm pretty confused by the hordes of anti-clotting drugs out there.

Note that BGEN has a royalty interest in the MDCO drug (it was originally a BGEN drug).

Peter